These findings suggest that chymase contributes to cardiac remodeling and diastolic dysfunction through mechanisms beyond Ang II generation—specifically, through the activation of latent TGF-β1 and pro-MMP-2—highlighting its independent and critical role in the pathogenesis of cardiac fibrosis and hypertrophy. The gene discussed is CMA1; the disease is cardiac hypertrophy.